The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.
1 | |
Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity |
ChemMedChem. 2022 Dec 30;e202200583. doi: 10.1002/cmdc.202200583.Online ahead of print.
Liridona Useini 1, Marija Mojic 2, Markus Laube 3, Peter Lönnecke 1, Sanja Mijatovic 2, Danijela Maksimovic-Ivanic 2, Jens Pietzsch 3 4, Evamarie Hey-Hawkins 1 |
2 | |
Gout Screening Identifies a Large Cardiovascular Population at Increased Risk of Mortality |
J Clin Rheumatol. 2022 Dec 1;28(8):409-415. doi: 10.1097/RHU.0000000000001890.Epub 2022 Jul 30.
Silvia Ruiz-Simón 1, Irene Calabuig 2, Miguel Gómez-Garberí 3, Mariano Andrés |
3 | |
Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial |
Arthritis Res Ther. 2022 Dec 27;24(1):281. doi: 10.1186/s13075-022-02979-4.
John K Botson 1, Katie Obermeyer 2, Brian LaMoreaux 2, Lin Zhao 2, Michael E Weinblatt 3, Jeff Peterson 4 |
4 | |
Factors associated with change in health-related quality of life in people with gout: a three-year prospective cohort study in primary care |
Rheumatology (Oxford). 2022 Dec 21;keac706. doi: 10.1093/rheumatology/keac706.Online ahead of print.
Lorraine Watson 1, John Belcher 1, Elaine Nicholls 1 2, Priyanka Chandratre 3, Milica Blagojevic-Bucknall 1, Samantha Hider 1 4, Sarah A Lawton 1, Christian D Mallen 1 4, Sara Muller 1, Keith Rome 5, Edward Roddy 1 4 |
5 | |
Interactions Between Genetic Risk and Diet Influencing Risk of Incident Female Gout: Discovery and Replication Analysis of Four Prospective Cohorts |
Arthritis Rheumatol. 2022 Dec 13. doi: 10.1002/art.42419. Online ahead of print.
Kehuan Lin 1 2 3, Natalie McCormick 2 3 4 5, Chio Yokose 2 3 5, Amit D Joshi 6, Na Lu 4 6, Gary C Curhan 6 7, Tony R Merriman 8 9, Kenneth G Saag 8, Paul M Ridker 10, Julie E Buring 1 10, Daniel I Chasman 10, Frank B Hu 1 6 11, Hyon K Choi 2 3 4 5 6 |
6 | |
Global burden of gout in 1990-2019: A systematic analysis of the Global Burden of Disease study 2019 |
Eur J Clin Invest. 2022 Dec 13;e13937. doi: 10.1111/eci.13937. Online ahead of print.
Yeon Jae Jeong 1, Seoyeon Park 1, Dong Keon Yon 2, Seung Won Lee 3, Kalthoum Tizaoui 4, Ai Koyanagi 5 6 7, Louis Jacob 5 8, Karel Kostev 9, Elena Dragioti 10, Joaquim Radua 11 12 13 14, Andrew Stickley 15, Hans Oh 16, Jae Il Shin 17, Lee Smith 18 |
7 | |
Treat-to-target urate-lowering therapy and hospitalisations for gout: results from a nationwide cohort study in England |
Rheumatology (Oxford). 2022 Nov 10;keac638. doi: 10.1093/rheumatology/keac638.Online ahead of print.
Mark D Russell 1, Edward Roddy 2, Andrew I Rutherford 3, Benjamin Ellis 4, Sam Norton 1, Abdel Douiri 5, Martin C Gulliford 5, Andrew P Cope 1, James B Galloway 1 |
8 | |
Orthopaedic Management of Gout |
J Am Acad Orthop Surg Glob Res Rev. 2022 Nov 8;6(11):e22.00216.doi: 10.5435/JAAOSGlobal-D-22-00216. eCollection 2022 Nov 1.
Anna R Cohen-Rosenblum 1, Jason R Somogyi, Kelly K Hynes, Myriam E Guevara |
9 | |
Evaluating the association between food insecurity and risk of nephrolithiasis: an analysis of the National Health and Nutrition Examination Survey |
World J Urol. 2022 Nov;40(11):2641-2647. doi: 10.1007/s00345-022-04150-9.Epub 2022 Sep 20.
Benjamin W Green 1, Kevin Labagnara 1, Eric Macdonald 1, Nathan Feiertag 1, Michael Zhu 1, Kavita Gupta 1, Charan Mohan 2, Kara L Watts 1, Arun Rai 2, Alexander C Small 3 |
10 | |
Development and Validation of an Emergency Department Electronic Medical Record Gout Flare Alert |
Arthritis Care Res (Hoboken). 2022 Nov 21. doi: 10.1002/acr.25061. Online ahead of print.
Lesley E Jackson 1, Narender Annapureddy 2, Megan E Hansen 2, Kenneth G Saag 1, James Booth 3, Giovanna Rosas 1, Phillip J Foster 1, Amy Mudano 1, Dongmei Sun 1, John D Osborne 4, Tim Bongartz 5, Erik Hess 5, Colleen Lawrence 6, Leah Dunkel 6, Maria I Danila 1 7 |
11 | |
Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions |
Br J Clin Pharmacol. 2022 Nov;88(11):4894-4901. doi: 10.1111/bcp.15435. Epub 2022 Jun 21.
Matthew J Coleshill 1 2, Richard O Day 1 2, Karson Tam 1, Mahsa Kouhkamari 3, Vincent Caillet 3, Eindra Aung 1 2, Diluk R W Kannangara 1 4, Peter Cronin 3, Anthony Rodgers 5, Sophie L Stocker 1 2 6 |
12 | |
Anti-Inflammatory and Hypouricemic Effect of Bioactive Compounds: Molecular Evidence and Potential Application in the Management of Gout |
Curr Issues Mol Biol. 2022 Oct 25;44(11):5173-5190. doi: 10.3390/cimb44110352.
Anna Scanu 1, Roberto Luisetto 2, Roberta Ramonda 1, Paolo Spinella 3, Paolo Sfriso 1, Paola Galozzi 1, Francesca Oliviero 1 |
14 | |
Monosodium urate deposition in the lumbosacral spine of patients with gout compared with non-gout controls: A dual-energy CT study |
Semin Arthritis Rheum. 2022 Oct;56:152064. doi: 10.1016/j.semarthrit.2022.152064.Epub 2022 Jun 30.
Michael Toprover 1, Michael Mechlin 2, Theodore Fields 3, Cheongeun Oh 4, Fabio Becce 5, Michael H Pillinger 6 |
15 | |
Onset of depression and anxiety among patients with gout after diagnosis: a population-based incident cohort study |
BMC Rheumatol. 2022 Oct 3;6(1):56. doi: 10.1186/s41927-022-00288-6.
Alyssa Howren 1 2 3, Eric C Sayre 3, Hyon K Choi 3 4, J Antonio Avina-Zubieta 3 5, Kam Shojania 3 5 6, Jamie Y Park 1 2 3, Mary A De Vera 7 8 9 10 |
16 | |
Predictors of Patient and Physician Assessments of Gout Control |
Arthritis Care Res (Hoboken). 2022 Oct 20. doi: 10.1002/acr.25046. Online ahead of print.
Nicola Dalbeth 1, Christopher Frampton 2, Maple Fung 3, Scott Baumgartner 3, Hyon K Choi 4 |
17 | |
Nationwide racial/ethnic disparities in US emergency department visits and hospitalizations for gout |
Rheumatology (Oxford). 2022 Oct 11;keac590. doi: 10.1093/rheumatology/keac590.Online ahead of print.
Chio Yokose 1 2, Natalie McCormick 1 2 3, Na Lu 3 4, Amit D Joshi 4, Lesley Jackson 5, Minna J Kohler 1, Janeth Yinh 1, Yuqing Zhang 1 2, John Hsu 6 7, Nicola Dalbeth 8, Kenneth G Saag 5, Hyon K Choi 1 2 |
18 | |
Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis |
Semin Arthritis Rheum. 2022 Oct;56:152049.doi: 10.1016/j.semarthrit.2022.152049. Epub 2022 Jun 15.
Ritch Te Kampe 1, Sabrina Mai Nielsen 2, Ioana Hotea 3, Caroline van Durme 4, Robin Christensen 2, Annelies Boonen 5 |
19 | |
The clinician's guide to prevention and treatment of osteoporosis |
Osteoporos Int. 2022 Oct;33(10):2049-2102. doi: 10.1007/s00198-021-05900-y.Epub 2022 Apr 28.
M S LeBoff 1, S L Greenspan 2, K L Insogna 3, E M Lewiecki 4, K G Saag 5, A J Singer 6, E S Siris 7 |
20 | |
Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout |
Rheumatol Ther. 2022 Dec;9(6):1549-1558. doi: 10.1007/s40744-022-00492-3.Epub 2022 Sep 22.
Aaron Broadwell 1, John A Albert 2, Lissa Padnick-Silver 3, Brian LaMoreaux 4 |
21 | |
Change in serum urate level with urate-lowering therapy initiation associates in the immediate term with patient-reported outcomes in people with gout |
Semin Arthritis Rheum. 2022 Oct;56:152057. doi: 10.1016/j.semarthrit.2022.152057.Epub 2022 Jun 29.
Ruth Topless 1, Siamak Noorbaloochi 2, Tony R Merriman 3, Jasvinder A Singh 4 |
22 | |
A Randomized Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR RCT): Primary Efficacy and Safety Findings |
Arthritis Rheumatol. 2022 Sep 13. doi: 10.1002/art.42335. Online ahead of print.
John K Botson 1, Kenneth Saag 2, Jeff Peterson 3, Naval Parikh 4, Stephen Ong 5, Dan La 6, Karon LoCicero 7, Katie Obermeyer 8, Yan Xin 8, Jason Chamberlain 8, Brian LaMoreaux 8, Supra Verma 8, Stephen Sainati 8, Suneet Grewal 9, Amar Majjhoo 10, John R P Tesser 11, Michael E Weinblatt 12 |
23 | |
In patients with acute mono-oligoarthritis, a targeted ultrasound scanning protocol shows great accuracy for the diagnosis of gout and CPPD |
Rheumatology (Oxford). 2022 Aug 23;keac479. doi: 10.1093/rheumatology/keac479.Online ahead of print.
Edoardo Cipolletta 1 2, Emilio Filippucci 1, Abhishek Abhishek 2, Jacopo Di Battista 1, Gianluca Smerilli 1, Marco Di Carlo 1, Ferdinando Silveri 1, Rossella De Angelis 1, Fausto Salaffi 1, Walter Grassi 1, Andrea Di Matteo 1 |
24 | |
Critical appraisal of serum urate targets in the management of gout |
Nat Rev Rheumatol. 2022 Aug 16. doi: 10.1038/s41584-022-00816-1.Online ahead of print.
|
25 | |
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study |
Clin Exp Rheumatol. 2022 Aug 5. doi: 10.55563/clinexprheumatol/eh0jcp. Online ahead of print.
Mariagrazia Lorenzin 1, Nicola Ughi 2, Alarico Ariani 3, Bernd Raffeiner 4, Paola Frallonardo 5, Ariela Hoxha 6, Augusta Ortolan 1, Marta Favero 7, Simone Parisi 8, Alessandra Bortoluzzi 9, Fulvia Ceccarelli 10, Ramona Lucchetti 10, Federica Furini 9, Teresa Del Ross 1, Anna Zanetti 11, Greta Carrara 12, Carlo Alberto Scirè 13, Andrea Doria 1, Roberta Ramonda 14, SIR Study Group ATTACk
Collaborators
Fausto Salaffi, Andrea Di Matteo, Enrico Fusaro, Marcello Govoni, Maria Manara, Antonella Murgo, Laura Rotunno, Marco Amadeo Cimmino |
26 | |
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study |
Arthritis Res Ther. 2022 Aug 25;24(1):208.doi: 10.1186/s13075-022-02865-z.
John K Botson 1, John R P Tesser 2, Ralph Bennett 2, Howard M Kenney 3, Paul M Peloso 4, Katie Obermeyer 4, Yang Song 5, Brian LaMoreaux 4, Lin Zhao 4, Yan Xin 5, Jason Chamberlain 5, Srini Ramanathan 5, Michael E Weinblatt 6, Jeff Peterson 7 |
28 | |
Effects of vitamin C supplementation on gout risk: results from the Physicians' Health Study II trial |
Am J Clin Nutr. 2022 Sep 2;116(3):812-819.doi: 10.1093/ajcn/nqac140.
Stephen P Juraschek 1, J Michael Gaziano 2 3, Robert J Glynn 4 5, Natalya Gomelskaya 4, Vadim Y Bubes 4, Julie E Buring 4 6, Robert H Shmerling 7, Howard D Sesso 2 4 6 |
29 | |
Treatment Guidelines in Gout |
Rheum Dis Clin North Am. 2022 Aug;48(3):659-678. doi: 10.1016/j.rdc.2022.04.003.
|
30 | |
A glance into the future of gout |
Ther Adv Musculoskelet Dis. 2022 Jul 28;14:1759720X221114098.doi: 10.1177/1759720X221114098. eCollection 2022.
|
31 | |
Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial |
Arthritis Rheumatol. 2022 Sep;74(9):1593-1601.doi: 10.1002/art.42160. Epub 2022 Aug 5.
Kenneth G Saag 1, Michael A Becker 2, William B White 3, Andrew Whelton 4, Jeffrey S Borer 5, Philip B Gorelick 6, Barbara Hunt 7, Majin Castillo 7, Lhanoo Gunawardhana 7, CARES Investigators Collaborators CARES Investigators: |
32 | |
Moving the Needle in Gout Management: The Role of Culture, Diet, Genetics, and Personalized Patient Care Practices |
Nutrients. 2022 Aug 31;14(17):3590. doi: 10.3390/nu14173590.
|
33 | |
Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom |
Lancet Reg Health Eur. 2022 May 25;18:100416. doi: 10.1016/j.lanepe.2022.100416.eCollection 2022 Jul.
Mark D Russell 1, Andrew I Rutherford 2, Benjamin Ellis 3, Sam Norton 1, Abdel Douiri 4, Martin C Gulliford 4, Andrew P Cope 1, James B Galloway 1 |
34 | |
Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout |
Br J Clin Pharmacol. 2022 Jul 18. doi: 10.1111/bcp.15462. Online ahead of print.
Bishoy Kamel 1 2 3 4, Ahmad Y Abuhelwa 5 6 7, David Foster 7, Janna K Duong 8, Garry G Graham 3 4, Kenneth M Williams 3 4, Kevin D Pile 9 10, Richard O Day 2 3 |
35 | |
Dual Energy CT Has Additional Prognostic Value over Clinical Measures in Gout Including Tophi: A Systematic Literature Review |
J Rheumatol. 2022 Jul 15;jrheum.211246. doi: 10.3899/jrheum.211246. Online ahead of print.
|
36 | |
Long-term follow-up of a randomised controlled trial of allopurinol dose escalation to achieve target serum urate in people with gout |
J Rheumatol. 2022 Jul 1;jrheum.220270. doi: 10.3899/jrheum.220270. Online ahead of print.
George B Coleman 1, Nicola Dalbeth 1, Chris Frampton 1, Janine Haslett 1, Jill Drake 1, Isabel Su 1, Anne M Horne 1, Lisa K Stamp 1 |
37 | |
Emerging strategies for treating gout |
Curr Opin Pharmacol. 2022 May 19;65:102241. doi: 10.1016/j.coph.2022.102241.Online ahead of print.
|
38 | |
Pharmacist knowledge of gout management: impact of an educational intervention |
BMC Rheumatol. 2022 May 23;6(1):30. doi: 10.1186/s41927-022-00259-x.
Emma R Dorris 1, Mariosa Kieran 2, Nicola Dalbeth 3, Geraldine McCarthy 4 5 |
39 | |
Gout and Hospital Admission for Ambulatory Care-Sensitive Conditions: Risks and Trajectories |
J Rheumatol. 2022 Jul;49(7):731-739. doi: 10.3899/jrheum.220038. Epub 2022 Apr 15.
|
40 | |
Gout increases length of stay in patients hospitalized for heart failure exacerbation |
Ther Adv Musculoskelet Dis. 2022 Jun 14;14:1759720X221102853.doi: 10.1177/1759720X221102853. eCollection 2022.
Daniel DeMizio 1, Guojing Wu 2, Ying Wei 2, Joan Bathon 3, Runsheng Wang 1 |
41 | |
Risk of gout flares after COVID-19 vaccination: A case-crossover study |
Semin Arthritis Rheum. 2022 Jun 28;56:152059. doi: 10.1016/j.semarthrit.2022.152059.Online ahead of print.
Hui Li 1, Nicola Dalbeth 2, Zachary S Wallace 3, Jeffrey A Sparks 4, Xiaoxiao Li 5, Chao Zeng 6, Yilun Wang 1, Dongxing Xie 1, Guanghua Lei 6, Jie Wei 7, Yuqing Zhang 8 |
42 | |
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout |
BMC Med Inform Decis Mak. 2022 Apr 7;22(1):95. doi: 10.1186/s12911-022-01833-6.
Ritch Te Kampe 1 2 3, Annelies Boonen 4 5, Tim L Jansen 6, Jan Mathis Elling 5 7, Marcel Flendrie 8, Yvonne van Eijk-Hustings 9, Matthijs Janssen 6, Caroline van Durme 4 10, Hein de Vries 5 7 |
43 | |
Professionals' perspectives on existing practice and conditions for nurse-led gout care based on treatment recommendations: a qualitative study in primary healthcare |
BMC Prim Care. 2022 Apr 7;23(1):71. doi: 10.1186/s12875-022-01677-z.
Helene Sedelius 1 2, Malin Tistad 3 4, Ulrika Bergsten 5, Mats Dehlin 6, David Iggman 7, Lars Wallin 3, Anna Svärd 7 |
44 | |
Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study |
Front Med (Lausanne). 2022 Feb 24;9:802856. doi: 10.3389/fmed.2022.802856.eCollection 2022.
Mats Dehlin 1, Tatiana Zverkova Sandström 1, Lennart Th Jacobsson 1 |
45 | |
Treating gout - can hypouricemia produced by moderate doses of combined oral treatment give early treatment success? Preliminary observations |
Nucleosides Nucleotides Nucleic Acids. 2022 Mar 8;1-12. doi: 10.1080/15257770.2022.2039394.Online ahead of print.
|
46 | |
Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure |
Clin Cardiol. 2022 Apr 28. doi: 10.1002/clc.23830. Online ahead of print.
Mary E Roth 1, Melissa E Chinn 1, Steven P Dunn 1, Kenneth C Bilchick 2, Sula Mazimba 2 |
47 | |
Enhancing the Response Rate to Recombinant Uricases in Patients with Gout |
BioDrugs. 2022 Mar;36(2):95-103. doi: 10.1007/s40259-022-00517-x.Epub 2022 Mar 22.
Naomi Schlesinger 1, Lissa Padnick-Silver 2, Brian LaMoreaux 3 |
48 | |
Update on gout management: what is old and what is new |
Curr Opin Rheumatol. 2022 Mar 1;34(2):118-124.doi: 10.1097/BOR.0000000000000861.
|
49 | |
Managing Cardiovascular Risk in Patients with Rheumatic Disease |
Rheum Dis Clin North Am. 2022 May;48(2):429-444. doi: 10.1016/j.rdc.2022.02.003. |
50 | |
Management and Cure of Gouty Arthritis |
Rheum Dis Clin North Am. 2022 May;48(2):479-492. doi: 10.1016/j.rdc.2022.03.001.
|
51 | |
Gout management and outcomes during established COVID-19 pandemic in 2020-2021: a cross-sectional Internet survey |
Ther Adv Musculoskelet Dis. 2022 May 13;14:1759720X221096381.doi: 10.1177/1759720X221096381. eCollection 2022.
|
52 | |
Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk: the FORWARD study |
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):236-242.doi: 10.1093/ehjcvp/pvaa144.
Giovambattista Desideri 1, Marek Rajzer 2, Martijn Gerritsen 3, Michael T Nurmohamed 4, Cristina Giannattasio 5, Anne-Kathrin Tausche 6, Claudio Borghi 7 |
53 | |
Update of the current role of ultrasound in asymptomatic hyperuricemia. A systematic literature review |
Joint Bone Spine. 2022 May;89(3):105335. doi: 10.1016/j.jbspin.2021.105335. Epub 2021 Dec 22.
Marwin Gutierrez 1, Hugo Sandoval 2, Chiara Bertolazzi 3, Carina Soto-Fajardo 3, Rene Martin Tellez-Gastelum 4, Anthony M Reginato 5, Denise Clavijo-Cornejo 6 |
54 | |
Erectile dysfunction in hyperuricemia: A prevalence meta-analysis and meta-regression study |
Andrology. 2022 Jan;10(1):72-81. doi: 10.1111/andr.13088. Epub 2021 Aug 16.
Maria Totaro 1, Sotirios Dimarakis 1, Chiara Castellini 1, Settimio D'Andrea 1, Antonio Parisi 1, Federica D'Amato 1, Daniele Tienforti 1, Sara Palazzi 1, Marco Giorgio Baroni 2, Sandro Francavilla 1, Arcangelo Barbonetti 1 |
55 | |
Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review |
Int J Pharm Pract. 2022 Apr 13;riac025. doi: 10.1093/ijpp/riac025. Online ahead of print.
Klarissa A Sinnappah 1, Sophie L Stocker 2 3 4, Jian Sheng Chan 3 4, Dyfrig A Hughes 5, Daniel F B Wright 1 |
56 | |
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial |
Diabetes Obes Metab. 2022 Jan;24(1):135-141.doi: 10.1111/dom.14559. Epub 2021 Oct 4.
João Pedro Ferreira 1 2, Silvio E Inzucchi 3, Michaela Mattheus 4, Thomas Meinicke 4, Dominik Steubl 4 5, Christoph Wanner 6, Bernard Zinman 7 |
57 | |
Treatment advances in gout |
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101719.doi: 10.1016/j.berh.2021.101719. Epub 2021 Oct 28.
|
58 | |
Managing Gout in Women: Current Perspectives |
J Inflamm Res. 2022 Mar 3;15:1591-1598. doi: 10.2147/JIR.S284759.eCollection 2022.
|
59 | |
Elevated Serum Uric Acid and Cardiovascular Disease: A Review and Potential Therapeutic Interventions |
Cureus. 2022 Mar 28;14(3):e23582. doi: 10.7759/cureus.23582.eCollection 2022 Mar.
Michael Freilich 1, Andrew Arredondo 1, Seyedeh Leila Zonnoor 1, Isabel M McFarlane 1 |
60 | |
Gout and the COVID-19 pandemic |
Curr Opin Rheumatol. 2022 Mar 1;34(2):111-117.doi: 10.1097/BOR.0000000000000860.
|
61 | |
Improvement in hepatic fibrosis estimated by Fibrosis-4 index in pegloticase treated chronic refractory gout patients |
Clin Exp Rheumatol. 2022 Mar 23. doi: 10.55563/clinexprheumatol/1138gr. Online ahead of print. Naomi Schlesinger 1, Vinod K Rustgi 2, Anthony E Yeo 3, Peter E Lipsky 4 |
62 | |
The challenge of gout flare measurement |
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101716.doi: 10.1016/j.berh.2021.101716. Epub 2021 Oct 9. |
63 | |
Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management |
NEJM Evid. 2022 Mar;1(3):10.1056/evidoa2100028. doi: 10.1056/evidoa2100028.Epub 2022 Feb 3. James R O'Dell 1 2, Mary T Brophy 3 4, Michael H Pillinger 5 6, Tuhina Neogi 7, Paul M Palevsky 8 9, Hongsheng Wu 3 10, Anne Davis-Karim 11, Jeff A Newcomb 1 2, Ryan Ferguson 3, David Pittman 11, Grant W Cannon 12, Thomas Taylor 13 14, Robert Terkeltaub 15, Amy C Cannella 1 2, Bryant R England 1 2, Lindsay N Helget 1 2, Ted R Mikuls 1 2 |
64 | |
Gout As a Predictor of Total Knee Arthroplasty Outcomes and Costs |
J Knee Surg. 2022 Mar;35(4):362-366. doi: 10.1055/s-0040-1715098. Epub 2020 Aug 24. Samuel Rosas # 1, Andrey Zuskov # 1, Tianyi David Luo 1, Martin W Roche 2, Cynthia L Emory 1, Johannes F Plate 1 |
65 | |
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease |
Am J Med. 2022 Jan;135(1):32-38. doi: 10.1016/j.amjmed.2021.07.025.Epub 2021 Aug 18. Philip C Robinson 1, Robert Terkeltaub 2, Michael H Pillinger 3, Binita Shah 4, Vangelis Karalis 5, Eleni Karatza 5, David Liew 6, Massimo Imazio 7, Jan H Cornel 8, Peter L Thompson 9, Mark Nidorf 10 |
66 | |
Does seasonality of the microbiota contribute to the seasonality of acute gout flare? |
Clin Exp Rheumatol. 2022 Mar 30. doi: 10.55563/clinexprheumatol/hdtge7.Online ahead of print. Naomi Schlesinger 1, Luigi Brunetti 2, Ioannis P Androulakis 3 |
67 | |
Randomised controlled trial targeting habit formation to improve medication adherence to daily oral medications in patients with gout |
BMJ Open. 2021 Nov 24;11(11):e055930.doi: 10.1136/bmjopen-2021-055930. Constance P Fontanet 1 2, Niteesh K Choudhry 1 2, Wendy Wood 3, Ted Robertson 4, Nancy Haff 1 2, Rebecca Oran 4, Ellen S Sears 1 2, Erin Kim 1 2, Kaitlin Hanken 1 2, Renee A Barlev 1 2, Julie C Lauffenburger 1, Candace H Feldman 5 6 |
68 | |
Temporal Trends in COVID-19 outcomes in People with Rheumatic Diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry |
Rheumatology (Oxford). 2022 Mar 8;keac142. doi: 10.1093/rheumatology/keac142.Online ahead of print. Richard Conway 1 2, Elena Nikiphorou 3 4, Christiana A Demetriou 5, Candice Low 6, Kelly Leamy 7, John G Ryan 8, Ronan Kavanagh 9, Alexander D Fraser 10 11, John J Carey 12 13, Paul O'Connell 14 15, Rachael M Flood 2 16, Ronan H Mullan 2 16, David J Kane 2 16, Nicola Ambrose 17, Frances Stafford 17, Philip C Robinson 18, Jean W Liew 19, Rebecca Grainger 20, Geraldine M McCarthy 7, COVID-19 Global Rheumatology Alliance |
69 | |
What's new on the front-line of gout pharmacotherapy? |
Expert Opin Pharmacother. 2022 Mar;23(4):453-464.doi: 10.1080/14656566.2021.2020249. Epub 2022 Jan 5. Kurt E G Blake 1, Jordan L Saag 2, Kenneth G Saag 3 |
70 | |
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response |
Curr Rheumatol Rep. 2022 Jan;24(1):12-19. doi: 10.1007/s11926-022-01055-9.Epub 2022 Feb 15. John K Botson 1, Herbert S B Baraf 2, Robert T Keenan 3, John Albert 4, Karim R Masri 5, Jeff Peterson 6, Christianne Yung 7, Brigid Freyne 8, Mona Amin 9, Abdul Abdellatif 10, Nehad Soloman 11, N Lawrence Edwards 12, Vibeke Strand 13 |
71 | |
U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia |
Redox Biol. 2022 Feb 17;51:102271. doi: 10.1016/j.redox.2022.102271.Online ahead of print. William T Crawley 1, Cyprien G Jungels 1, Kurt R Stenmark 2, Mehdi A Fini 3 |
72 | |
Racial Disparities in the Modern Gout Epidemic |
J Rheumatol. 2022 Mar 15;jrheum.220173. doi: 10.3899/jrheum.220173.Online ahead of print. Natalie McCormick 1, Hyon K Choi 1 |
73 | |
Cause-Specific Mortality in Patients with Gout in the United States Veteran's Health Administration: A Matched Cohort Study |
Arthritis Care Res (Hoboken). 2022 Mar 16. doi: 10.1002/acr.24881. Online ahead of print. Lindsay N Helget 1 2, Bryant R England 1 2, Punyasha Roul 1 2, Harlan Sayles 2 3, Alison D Petro 1 2, Tuhina Neogi 4, James R O'Dell 1 2, Ted R Mikuls 1 2 |
74 | |
Hospitalizations for acute gout: process mapping the inpatient journey and identifying predictors of admission |
J Rheumatol. 2022 Mar 15;jrheum.211203. doi: 10.3899/jrheum.211203. Online ahead of print. Mark D Russell 1, Deepak Nagra 1, Benjamin D Clarke 1, Sathiyaa Balachandran 1, April Buazon 1, Amy Boalch 1, Katie Bechman 1, Maryam A Adas 1, Edward G Alveyn 1, Andrew I Rutherford 1, James B Galloway 1 |
75 | |
Disease modification in gout: a qualitative study of gout expert rheumatologists |
Rheumatol Adv Pract. 2022 Jan 3;6(1):rkab107. doi: 10.1093/rap/rkab107. eCollection 2022. Jasvinder A Singh 1 2 |
76 | |
Gout gone awry: The importance of proper diagnosis |
Clin Case Rep. 2021 Dec 16;9(12):e05201. doi: 10.1002/ccr3.5201. eCollection 2021 Dec. Sophia Tessema 1, Abdullahi E Mahgoub 2, Rasha Nakhleh 3 |
77 | |
The relationship between metabolic syndrome severity and the risk of mortality in gout patients: a population-based study |
Clin Exp Rheumatol. 2022 Feb 1. Online ahead of print. Naomi Schlesinger 1, Mohamed I Elsaid 2, Vinod K Rustgi 3 |
78 | |
Pegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels |
Clin Exp Rheumatol. 2022 Feb 25. Online ahead of print. Robert T Keenan 1, Anthony E Yeo 2, Peter E Lipsky 3 |
79 | |
Gout Arthritis During Admission for Decompensated Heart Failure-A Descriptive Analysis of Risk Factors, Treatment and Prognosis |
Front Med (Lausanne). 2022 Feb 14;9:789414. doi: 10.3389/fmed.2022.789414.eCollection 2022. Fabian Ritter 1, Fabian Franzeck 2, Julian Geisshardt 1, Ulrich A Walker 3, Michael Osthoff 1 4 |
80 | |
A systematic review of the drug-drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies |
Pharmacotherapy. 2022 Feb 17. doi: 10.1002/phar.2674. Online ahead of print. Nicholas C Schwier 1, Cyrille K Cornelio 2, Paul M Boylan 1 |
81 | |
Why do patients with gout not take allopurinol? |
J Rheumatol. 2022 Feb 15;jrheum.210950. doi: 10.3899/jrheum.210950. Online ahead of print. Yasaman Emad 1, Nicola Dalbeth 1, John Weinman 1, Trudie Chalder 1, Keith J Petrie 1 |
82 | |
Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study |
Lancet Rheumatol. 2022 Jan 28. doi: 10.1016/S2665-9913(21)00401-X. Online ahead of print. Ruth K Topless 1, Angelo Gaffo 2 3, Lisa K Stamp 4, Philip C Robinson 5, Nicola Dalbeth 6, Tony R Merriman 1 2 |
83 | |
Modifiable Factors and Incident Gout across Ethnicity within a Large Multiethnic Cohort of Older Adults |
J Rheumatol. 2022 Feb 1;jrheum.210394. doi: 10.3899/jrheum.210394. Online ahead of print. Mika D Thompson 1, Yan Yan Wu 1, Robert V Cooney 1, Lynne R Wilkens 1, Christopher A Haiman 1, Catherine M Pirkle 1 |
84 | |
Is repeat serum urate testing superior to a single test to predict incident gout over time? |
PLoS One. 2022 Feb 1;17(2):e0263175. doi: 10.1371/journal.pone.0263175. eCollection 2022. Sarah Stewart 1, Amanda Phipps-Green 2, Greg D Gamble 1, Lisa K Stamp 3, William J Taylor 4, Tuhina Neogi 5, Tony R Merriman 2, Nicola Dalbeth 1 |
85 | |
The Relation of Accelerometer-Measured Physical Activity and Serum Uric Acid Using the National Health and Nutrition Survey (NHANES) 2003-2004 |
Front Sports Act Living. 2022 Jan 12;3:775398. doi: 10.3389/fspor.2021.775398.eCollection 2021. Isaac D Smith 1 2, Leanna M Ross 1 3, Josi R Gabaldon 3 4, Nicholas Holdgate 5, Carl F Pieper 6, Tony C Ning 7, William E Kraus 1 3 8, Kim M Huffman 1 2 3 |
86 | |
Gouty Arthropathy: Review of Clinical Manifestations and Treatment, with Emphasis on Imaging |
J Clin Med. 2021 Dec 29;11(1):166. doi: 10.3390/jcm11010166. Jennifer S Weaver 1, Ernest R Vina 2, Peter L Munk 3 4, Andrea S Klauser 5, Jamie M Elifritz 6 7, Mihra S Taljanovic 1 8 |
87 | |
Gout Flare Severity From the Patient Perspective: A Qualitative Interview Study |
Arthritis Care Res (Hoboken). 2022 Feb;74(2):317-323. doi: 10.1002/acr.24475.Epub 2022 Jan 8. Andrea Garcia-Guillen 1, Sarah Stewart 2, Isabel Su 2, William J Taylor 3, Angelo L Gaffo 4, Merryn Gott 2, Julia Slark 2, Anne Horne 2, Nicola Dalbeth 2 |
88 | |
Pretreatment and Coadministration With Methotrexate Improved Durability of Pegloticase Response: An Observational, Proof-of-Concept Case Series |
J Clin Rheumatol. 2022 Jan 1;28(1):e129-e134.doi: 10.1097/RHU.0000000000001639. |
89 | |
Mortality in Patients With Gout Treated With Allopurinol: A Systematic Review and Meta-Analysis |
Arthritis Care Res (Hoboken). 2021 Jul;73(7):1049-1054.doi: 10.1002/acr.24205. Epub 2021 Jun 18. Charles A Hay 1, James A Prior 1, John Belcher 1, Christian D Mallen 1, Edward Roddy 1 |
90 | |
Effectiveness of Allopurinol in Reducing Mortality: Time-Related Biases in Observational Studies |
Arthritis Rheumatol. 2021 Sep;73(9):1749-1757. doi: 10.1002/art.41710.Epub 2021 Jul 27. |
91 | |
Consensus-based semi-quantitative ultrasound scoring system for gout lesions: Results of an OMERACT Delphi process and web-reliability exercise |
Semin Arthritis Rheum. 2021 Jun;51(3):644-649. doi: 10.1016/j.semarthrit.2020.11.011.Epub 2021 Jan 10. Sara Nysom Christiansen 1, Georgios Filippou 2, Carlo Alberto Scirè 3, Peter V Balint 4, George Aw Bruyn 5, Nicola Dalbeth 6, Christian Dejaco 7, Andrea Delle Sedie 8, Emilio Filippucci 9, Hilde B Hammer 10, Annamaria Iagnocco 11, Helen I Keen 12, Eugene Y Kissin 13, Juhani Koski 14, Peter Mandl 15, Julia Martin 6, Eugenio De Miguel 16, Ingrid Möller 17, Esperanza Naredo 18, Carlos Pineda 19, Wolfgang A Schmidt 20, Sarah Stewart 6, Maria Antonietta D'Agostino 21, Lene Terslev 22, on the behalf of the OMERACT Ultrasound working group |
92 | |
Hyperuricaemia, gout and allopurinol in the CKD Queensland registry |
J Nephrol. 2021 Jun;34(3):753-762. doi: 10.1007/s40620-020-00937-4. Epub 2021 Jan 13. A Jeyaruban 1 2 3, W Hoy 4 5, A Cameron 4 5, H Healy 4 5 6, Z Wang 4 5, J Zhang 4 5, A Mallett 4 5 6 |
93 | |
Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis |
Clin Infect Dis. 2021 Oct 5;73(7):e2457-e2562. doi: 10.1093/cid/ciaa1238. JeanAnne M Ware 1, Elise M O'Connell 1, Thomas Brown 1, Lauren Wetzler 1, Kawsar R Talaat 2, Thomas B Nutman 1, Theodore E Nash 1 |
94 | |
Serious Infections in Patients With Gout in the US: A National Study of Incidence, Time Trends, and Outcomes |
Arthritis Care Res (Hoboken). 2021 Jun;73(6):898-908. doi: 10.1002/acr.24201. |
95 | |
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout |
RMD Open. 2021 Apr;7(2):e001623. doi: 10.1136/rmdopen-2021-001623. Rachel Murdoch 1, Michael J Barry 2, Hyon K Choi 3, Daniel Hernandez 4, Brianne Johnsen 3, Manuel Labrador 5, Susan Reid 1, Jasvinder A Singh 6 7, Robert Terkeltaub 8, Janitzia Vázquez Mellado 5, Nicola Dalbeth 9 |
96 | |
How to Differentiate Gout, Calcium Pyrophosphate Deposition Disease, and Osteoarthritis Using Just Four Clinical Parameters |
Diagnostics (Basel). 2021 May 21;11(6):924. doi: 10.3390/diagnostics11060924. Dmitrij Kravchenko 1, Raoul Bergner 2, Charlotte Behning 3, Valentin Sebastian Schäfer 4 |
97 | |
Different Food Sources of Fructose-Containing Sugars and Fasting Blood Uric Acid Levels: A Systematic Review and Meta-Analysis of Controlled Feeding Trials |
J Nutr. 2021 Aug 7;151(8):2409-2421. doi: 10.1093/jn/nxab144. Sabrina Ayoub-Charette 1 2, Laura Chiavaroli 1 2, Qi Liu 1 2, Tauseef Ahmad Khan 1 2, Andreea Zurbau 1 2 3, Fei Au-Yeung 1 2 3, Annette Cheung 1 2, Amna Ahmed 1 2, Danielle Lee 1 2, Vivian L Choo 1 2 4, Sonia Blanco Mejia 1 2, Russell J de Souza 1 2 5 6, Thomas Ms Wolever 1 2 3 7 8, Lawrence A Leiter 1 2 7 8 9, Cyril Wc Kendall 1 2 10, David Ja Jenkins 1 2 7 8 9, John L Sievenpiper 1 2 7 8 9 |
98 | |
COVID-19 in patients with gout on colchicine |
Rheumatol Int. 2021 Aug;41(8):1503-1507. doi: 10.1007/s00296-021-04902-7.Epub 2021 Jun 5. Eleftherios Pelechas 1, Vassiliki Drossou 1, Paraskevi V Voulgari 1, Alexandros A Drosos 2 |
99 | |
Allopurinol hepatotoxicity is associated with human leukocyte antigen Class I alleles |
Liver Int. 2021 Aug;41(8):1884-1893. doi: 10.1111/liv.14903. Epub 2021 May 7. Robert J Fontana 1, Yi-Ju Li 2, Elizabeth Phillips 3, Naba Saeed 4, Huiman Barnhart 2, David Kleiner 5, Jay Hoofnagle 6, Drug Induced Liver Injury Network |
100 | |
A patient-centered gout information value chain: a scoping review |
Patient Educ Couns. 2021 Jun 8;S0738-3991(21)00405-5.doi: 10.1016/j.pec.2021.06.007. Online ahead of print. |
101 | |
Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis |
Semin Arthritis Rheum. 2021 Apr 25;51(4):677-684. doi: 10.1016/j.semarthrit.2021.04.011.Online ahead of print. Chang-Nam Son 1, Sarah Stewart 2, Isabel Su 2, Borislav Mihov 2, Gregory Gamble 2, Nicola Dalbeth 3 |
102 | |
Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis |
Front Med (Lausanne). 2021 Jun 15;8:698437. doi: 10.3389/fmed.2021.698437.eCollection 2021. Shengzhao Zhang 1 2, Ting Xu 1 2, Qingyang Shi 3, Sheyu Li 4 3, Ling Wang 2, Zhenmei An 4, Na Su 1 2 |
103 | |
Improving outcomes for patients hospitalised with gout: a systematic review |
Rheumatology (Oxford). 2021 Jul 10;keab539. doi: 10.1093/rheumatology/keab539.Online ahead of print. Mark D Russell 1, Benjamin D Clarke 1, Edward Roddy 2 3, James B Galloway 1 |
104 | |
Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities |
Eur J Hum Genet. 2021 Feb 26. doi: 10.1038/s41431-021-00830-z. Online ahead of print. Richard J Reynolds 1, M Ryan Irvin 2, S Louis Bridges 3, Hwasoon Kim 4, Tony R Merriman 3 5, Donna K Arnett 6, Jasvinder A Singh 3 7, Nicholas A Sumpter 3, Alexa S Lupi 8 9, Ana I Vazquez 10 11 |
105 | |
The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: diet has a weak causal effect |
Arthritis Res Ther. 2021 Mar 4;23(1):75. doi: 10.1186/s13075-021-02444-8. Ruth K G Topless # 1, Tanya J Major # 1, Jose C Florez 2 3 4, Joel N Hirschhorn 2 5 6, Murray Cadzow 1, Nicola Dalbeth 7, Lisa K Stamp 8, Philip L Wilcox 9, Richard J Reynolds 10, Joanne B Cole # 2 3 5, Tony R Merriman # 11 12 |
106 | |
Awareness of and reactions to the health harms of sugary drinks: An online study of U.S. parents |
Appetite. 2021 Sep 1;164:105234. doi: 10.1016/j.appet.2021.105234. Epub 2021 Apr 3. Alexandra E Carl 1, Lindsey Smith Taillie 2, Anna H Grummon 3, Allison J Lazard 4, Isabella C A Higgins 5, Jennifer Mendel Sheldon 6, Marissa G Hall 7 |
107 | |
Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank |
Ann Rheum Dis. 2021 Apr 8;annrheumdis-2020-219796.doi: 10.1136/annrheumdis-2020-219796. Online ahead of print. Gabriela Sandoval-Plata 1 2 3, Kevin Morgan 3, Abhishek Abhishek 4 2 |
108 | |
Among the Company That Gout Keeps, Is Cancer on the List? |
J Rheumatol. 2021 May 15;jrheum.210138. doi: 10.3899/jrheum.210138.Online ahead of print. |
109 | |
Allopurinol and Renal Outcomes in Adults With and Without Type 2 Diabetes: A Retrospective, Population-Based Cohort Study and Propensity Score Analysis |
Can J Diabetes. 2021 Jan 20;S1499-2671(21)00005-8. doi: 10.1016/j.jcjd.2021.01.005.Online ahead of print. Alanna Weisman 1, George A Tomlinson 2, Lorraine L Lipscombe 3, Amit X Garg 4, Bruce A Perkins 5, David Z I Cherney 6, Gillian A Hawker 3 |
110 | |
Effects of Dietary Patterns on Serum Urate: Results From a Randomized Trial of the Effects of Diet on Hypertension |
Arthritis Rheumatol. 2021 Jun;73(6):1014-1020. doi: 10.1002/art.41614. Epub 2021 Apr 23. Stephen P Juraschek 1, Chio Yokose 2, Natalie McCormick 2, Edgar R Miller 3rd 3, Lawrence J Appel 3, Hyon K Choi 2 |
111 | |
Management and Cure of Gouty Arthritis |
Med Clin North Am. 2021 Mar;105(2):297-310. doi: 10.1016/j.mcna.2020.09.013.Epub 2021 Jan 14. |
112 | |
A Randomized Pilot Study of DASH Patterned Groceries on Serum Urate in Individuals with Gout |
Nutrients. 2021 Feb 7;13(2):538. doi: 10.3390/nu13020538. Stephen P Juraschek 1, Edgar R Miller 3rd 2, Beiwen Wu 2, Karen White 2, Jeanne Charleston 2, Allan C Gelber 2, Sharan K Rai 3, Kathryn A Carson 2, Lawrence J Appel 2, Hyon K Choi 4 |
113 | |
Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study |
Sarcoma. 2020 Dec 1;2020:8844970. doi: 10.1155/2020/8844970. eCollection 2020. Assaf Moore 1 2, Idit Peretz 1, Lilach Yosef 1, Daniel A Goldstein 1 2, Hadar Goldvaser 1 2, Suzanna Horn 2 3, Yonatan Edel 2 4 5, Alona Zer 1 2 |
114 | |
Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update |
Medicina (Kaunas). 2021 Jan 10;57(1):58. doi: 10.3390/medicina57010058. Arrigo F G Cicero 1, Federica Fogacci 1, Masanari Kuwabara 2, Claudio Borghi 1 |
115 | |
Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares |
Clin Exp Rheumatol. 2021 Jan 6. Online ahead of print. Brian F Mandell 1, Theodore R Fields 2, N Lawrence Edwards 3, Anthony E Yeo 4, Peter E Lipsky 5 |
116 | |
Hyperuricemia and Cardiovascular Risk |
Cureus. 2021 May 5;13(5):e14855. doi: 10.7759/cureus.14855. Lauren Shahin 1, Komal M Patel 1, Milad K Heydari 1, Marc M Kesselman 1 |
117 | |
Gout Flare Burden, Diagnosis, and Management: Navigating Care in Older Patients with Comorbidity |
Drugs Aging. 2021 Jun 9. doi: 10.1007/s40266-021-00866-2. Online ahead of print. |
118 | |
Gout in Pregnancy: A Rare Phenomenon |
Cureus. 2020 Nov 25;12(11):e11697. doi: 10.7759/cureus.11697. Kevin Pierre 1, Noah F Gomez 2, Catarina Canha 3, Ghania Masri 4 |
119 | |
Beyond Arthritis: Understanding the Influence of Gout on Erectile Function: A Systematic Review |
Urology. 2020 Dec 17;S0090-4295(20)31492-8. doi: 10.1016/j.urology.2020.12.005.Online ahead of print. Kyle Park 1, Nikhil K Gupta 2, Ephrem O Olweny 2, Naomi Schlesinger 3 |
120 | |
Ultrasonography and dual-energy computed tomography: impact for the detection of gouty deposits |
Ultrasonography. 2021 Apr;40(2):197-206. doi: 10.14366/usg.20063. Epub 2020 Oct 2. Christoph Schwabl 1, Mihra Taljanovic 2, Gerlig Widmann 1, James Teh 3, Andrea S Klauser 1
|
121 | |
Gout in primary total knee arthroplasty: Prevalent but not independently associated with complications |
Knee. 2021 Jan;28:45-50. doi: 10.1016/j.knee.2020.11.007. Epub 2020 Dec 6. Alexander T Bradley 1, Connor A King 2, Anna Cohen-Rosenblum 3, Peter K Sculco 4, David C Landy 5 |
122 | |
Contentious Issues in Gout Management: The Story so Far |
Open Access Rheumatol. 2021 May 12;13:111-122. doi: 10.2147/OARRR.S282631.eCollection 2021. |
123 | |
Limitations of dual-energy CT in the detection of monosodium urate deposition in dense liquid tophi and calcified tophi |
Skeletal Radiol. 2021 Feb 2. doi: 10.1007/s00256-021-03715-w. Online ahead of print. Se Jin Ahn 1, Dawen Zhang 2 3, Benjamin D Levine 4, Nicola Dalbeth 5, Bregina Pool 5, Veena K Ranganath 6, Prosper Benhaim 7, Scott D Nelson 8, Scott S Hsieh 9, John D FitzGerald 7 10 |
124 | |
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes |
Am J Cardiovasc Drugs. 2020 Dec 28;1-14. doi: 10.1007/s40256-020-00459-1.Online ahead of print. Subuhi Kaul 1, Manasvi Gupta 2, Dhrubajyoti Bandyopadhyay 3, Adrija Hajra 4, Prakash Deedwania 5, Edward Roddy 6, Mamas Mamas 7, Allan Klein 8, Carl J Lavie 9, Gregg C Fonarow 10, Raktim K Ghosh 11 |
125 | |
Identification of Gout Flares in Chief Complaint Text Using Natural Language Processing |
AMIA Annu Symp Proc. 2021 Jan 25;2020:973-982. eCollection 2020. John D Osborne 1, James S Booth 1, Tobias O'Leary 1, Amy Mudano 1, Giovanna Rosas 1, Phillip J Foster 1, Kenneth G Saag 1, Maria I Danila 1 |
126 | |
Assessing the Causal Relationships between Insulin Resistance and Hyperuricemia and Gout Using Bidirectional Mendelian Randomization |
Arthritis Rheumatol. 2021 May 13. doi: 10.1002/art.41779. Online ahead of print. Natalie McCormick 1 2 3 4, Mark J O'Connor 5, Chio Yokose 1 2 3, Tony R Merriman 6 7, David B Mount 3 8, Aaron Leong 3 9 10 11, Hyon K Choi 1 2 3 4 |
127 | |
The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis |
Rheumatol Int. 2021 May 13. doi: 10.1007/s00296-021-04876-6. Online ahead of print. Peter Cox 1, Sonal Gupta 2, Sizheng Steven Zhao 3, David M Hughes 4 |
128 | |
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine |
Ann Rheum Dis. 2020 Dec 8;annrheumdis-2020-219174.doi: 10.1136/annrheumdis-2020-219174. Online ahead of print. Aaron Z Reyes 1, Kelly A Hu 1, Jacob Teperman 1, Theresa L Wampler Muskardin 2 3, Jean-Claude Tardif 4, Binita Shah 5 6, Michael H Pillinger 7 8 |
129 | |
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study |
Rheumatol Ther. 2021 Mar;8(1):183-197. doi: 10.1007/s40744-020-00260-1. Epub 2020 Dec 7. Megan Francis-Sedlak 1, Brian LaMoreaux 2, Lissa Padnick-Silver 2, Robert J Holt 2, Alfonso E Bello 3 |
130 | |
Wastewater-based prevalence trends of gout in an Australian community over a period of 8 years |
Sci Total Environ. 2021 Mar 10;759:143460. doi: 10.1016/j.scitotenv.2020.143460.Epub 2020 Nov 9. Fahad Ahmed 1, Benjamin Tscharke 2, Jake W O'Brien 2, Qiuda Zheng 2, Jack Thompson 2, Jochen F Mueller 2, Kevin V Thomas 2 |
131 | |
Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial |
Am J Kidney Dis. 2021 Apr;77(4):481-489.doi: 10.1053/j.ajkd.2020.09.009. Epub 2020 Oct 29. Austin G Stack 1, Nalina Dronamraju 2, Joanna Parkinson 3, Susanne Johansson 3, Eva Johnsson 3, Fredrik Erlandsson 3, Robert Terkeltaub 4 |
132 | |
Designing a Strategy Trial for the Management of Gout: the use of a Modified Delphi Panel |
ACR Open Rheumatol. 2021 May 1. doi: 10.1002/acr2.11243. Online ahead of print. Daniel H Solomon 1, Joel S Weissman 1, Hyon Choi 2, Steven J Atlas 2, Cesar Berardinelli 3, Julien Dedier 4, Michael A Fischer 1, John Fitzgerald 5, Erica Hinteregger 1, Brianne Johnsen 2, Diana D Marini 3, Robert McLean 6, Fred Murray 3, Tuhina Neogi 4, Lynn B Oertel 2, Michael H Pillinger 7, Kevin R Riggs 8, Ken Saag 8, Dong Suh 1, James Watkins 3, Michael J Barry 2 |
133 | |
Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank |
ACR Open Rheumatol. 2021 Apr 15. doi: 10.1002/acr2.11252. Online ahead of print. Ruth K Topless 1, Amanda Phipps-Green 1, Megan Leask 2, Nicola Dalbeth 3, Lisa K Stamp 4, Philip C Robinson 5, Tony R Merriman 2 |
134 | |
Epidemiology and Outcomes of Alcohol Use Hospitalizations in People With Gout, Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, or Low Back Pain: A National US Study |
J Clin Rheumatol. 2021 Mar 25. doi: 10.1097/RHU.0000000000001731. Online ahead of print. |
135 | |
A neutrophil signature is strongly associated with increased cardiovascular risk in gout |
Rheumatology (Oxford). 2020 Nov 14;keaa712. doi: 10.1093/rheumatology/keaa712.Online ahead of print. Daisy Vedder 1 2, Martijn Gerritsen 1, Michael T Nurmohamed 1 2 3, Ronald F van Vollenhoven 1 3, Christian Lood 4 |
136 | |
Estimation of Primary Prevention of Gout in Men Through Modification of Obesity and Other Key Lifestyle Factors |
JAMA Netw Open. 2020 Nov 2;3(11):e2027421.doi: 10.1001/jamanetworkopen.2020.27421. Natalie McCormick 1 2 3 4, Sharan K Rai 4 5, Na Lu 4 6, Chio Yokose 1 2 3, Gary C Curhan 6 7, Hyon K Choi 1 2 3 4 |
137 | |
Something Old, Something New: the ACR Gout Treatment Guideline and Its Evolution from 2012 to 2020 |
Rebecca E Cohen 1, Michael H Pillinger 1 2, Michael Toprover 3 4 5 |
139 | |
The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis |
J Pers Med. 2021 Mar 22;11(3):231. doi: 10.3390/jpm11030231. |
140 | |
Gout: Rapid Evidence Review |
Am Fam Physician. 2020 Nov 1;102(9):533-538. |
141 | |
Puzzling Out the Colchicine Biosynthetic Pathway |
ChemMedChem. 2021 Feb 17;16(4):621-623. doi: 10.1002/cmdc.202000633.Epub 2020 Nov 9. |
142 | |
Management of Rheumatic Diseases During the COVID-19 pandemic: A National Veterans Affairs Survey of Rheumatologists |
Arthritis Care Res (Hoboken). 2020 Oct 15;10.1002/acr.24487. doi: 10.1002/acr.24487.Online ahead of print. Jasvinder A Singh 1 2 3, John S Richards 4, Elizabeth Chang 5, Amy Joseph 6 7, Bernard Ng 8 9 |
143 | |
Allopurinol use and type 2 diabetes incidence among patients with gout: A VA retrospective cohort study |
Medicine (Baltimore). 2020 Aug 28;99(35):e21675.doi: 10.1097/MD.0000000000021675. Anastasia Slobodnick 1 2, Michael Toprover 1 2, Jeffrey Greenberg 2, Daria B Crittenden 2, Virginia C Pike 1 2, Yingzhi Qian 3, Hua Zhong 3, Michael H Pillinger 1 2 |
144 | |
Latent Class Growth Analysis of Gout Flare Trajectories: A Three-Year Prospective Cohort Study in Primary Care |
Arthritis Rheumatol. 2020 Nov;72(11):1928-1935. doi: 10.1002/art.41476. Epub 2020 Oct 3. Lorraine Watson 1, John Belcher 1, Elaine Nicholls 1 2, Sara Muller 1, Christian Mallen 1 3 4, Edward Roddy 1 3 |
145 | |
Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy? |
Ther Innov Regul Sci. 2021 Jan;55(1):138-141. doi: 10.1007/s43441-020-00198-0.Epub 2020 Jul 13. Matthew J Coleshill 1 2, Eindra Aung 3 4, Jane E Carland 3 4, Kate Faasse 5, Sophie Stocker 3 4, Richard O Day 3 4 |
146 | |
Use of electronic recruitment methods in a clinical trial of adults with gout |
Clin Trials. 2021 Feb;18(1):92-103. doi: 10.1177/1740774520956969. Epub 2020 Sep 15. Hailey N Miller 1 2, Jeanne Charleston 2 3, Beiwen Wu 3, Kelly Gleason 1 2, Karen White 3, Cheryl R Dennison Himmelfarb 1 2, Daniel E Ford 2 3, Timothy B Plante 4, Allan C Gelber 3 5, Lawrence J Appel 2 3 5, Edgar R Miller 3rd 2 3 5, Stephen P Juraschek 6 |
147 | |
Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR) |
J Rheumatol. 2020 Sep 15;jrheum.200460. doi: 10.3899/jrheum.200460. Online ahead of print. John K Botson 1, John R P Tesser 1, Ralph Bennett 1, Howard M Kenney 1, Paul M Peloso 1, Katie Obermeyer 1, Brian LaMoreaux 1, Michael E Weinblatt 1, Jeff Peterson 1 |
148 | |
Cardiovascular safety risks associated with gout treatments |
Expert Opin Drug Saf. 2020 Sep;19(9):1143-1154.doi: 10.1080/14740338.2020.1804551. Epub 2020 Aug 12. Giovanna Rosas 1, Angelo Gaffo 1, Elizabeth J Rahn 1, Kenneth G Saag 1 |
149 | |
Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study |
Rheumatol Ther. 2020 Sep;7(3):639-648. doi: 10.1007/s40744-020-00222-7. Epub 2020 Jul 27. |
150 | |
Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review |
BJGP Open. 2020 Aug 25;4(3):bjgpopen20X101051. doi: 10.3399/bjgpopen20X101051.Print 2020 Aug. Iqbal Gill 1, Nicola Dalbeth 2, Malakai 'Ofanoa 3, Felicity Goodyear-Smith 4 |
151 | |
Therapeutic approaches in the treatment of gout |
Semin Arthritis Rheum. 2020 Jun;50(3S):S24-S30.doi: 10.1016/j.semarthrit.2020.04.010. |
152 | |
The experience of a gout flare: a meta-synthesis of qualitative studies |
Semin Arthritis Rheum. 2020 Aug;50(4):805-811.doi: 10.1016/j.semarthrit.2020.06.001. Epub 2020 Jun 9. Sarah Stewart 1, Andrea Garcia Guillen 2, William J Taylor 3, Angelo Gaffo 4, Julia Slark 5, Merryn Gott 6, Nicola Dalbeth 7 |
153 | |
Article placement order in rheumatology journals: a content analysis |
BMJ Open. 2020 Jun 17;10(6):e034550. doi: 10.1136/bmjopen-2019-034550. Sarah Stewart 1, Greg Gamble 1, Andrew Grey 1, Nicola Dalbeth 2 |
154 | |
Colchicine Prophylaxis of Gout Flares When Commencing Allopurinol is Very Cost Effective |
Arthritis Care Res (Hoboken). 2020 Jun 17. doi: 10.1002/acr.24357. Online ahead of print. |
155 | |
Changing paradigms in the management of gout |
J R Coll Physicians Edinb. 2020 Jun;50(2):124-132. doi: 10.4997/JRCPE.2020.209. |
156 | |
Development of a multivariable improvement measure for gout |
Arthritis Res Ther. 2020 Jun 29;22(1):164. doi: 10.1186/s13075-020-02254-4. Naomi Schlesinger 1, N Lawrence Edwards 2, Anthony E Yeo 3, Peter E Lipsky 4 |
157 | |
2020 American College of Rheumatology Guideline for the Management of Gout |
Arthritis Care Res (Hoboken). 2020 Jun;72(6):744-760.doi: 10.1002/acr.24180. Epub 2020 May 11. John D FitzGerald 1, Nicola Dalbeth 2, Ted Mikuls 3, Romina Brignardello-Petersen 4, Gordon Guyatt 4, Aryeh M Abeles 5, Allan C Gelber 6, Leslie R Harrold 7, Dinesh Khanna 8, Charles King 9, Gerald Levy 10, Caryn Libbey 11, David Mount 12, Michael H Pillinger 5, Ann Rosenthal 13, Jasvinder A Singh 14, James Edward Sims 15, Benjamin J Smith 16, Neil S Wenger 17, Sangmee Sharon Bae 17, Abhijeet Danve 18, Puja P Khanna 19, Seoyoung C Kim 20, Aleksander Lenert 21, Samuel Poon 22, Anila Qasim 4, Shiv T Sehra 23, Tarun Sudhir Kumar Sharma 24, Michael Toprover 5, Marat Turgunbaev 25, Linan Zeng 4, Mary Ann Zhang 20, Amy S Turner 25, Tuhina Neogi 11 |
158 | |
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout |
Arthritis Res Ther. 2020 Mar 12;22(1):45. doi: 10.1186/s13075-020-2136-z. Rebekah Wrigley 1, Amanda J Phipps-Green 1, Ruth K Topless 1, Tanya J Major 1, Murray Cadzow 1, Philip Riches 2, Anne-Kathrin Tausche 3, Matthijs Janssen 4, Leo A B Joosten 5 6, Tim L Jansen 4, Alexander So 7, Jennie Harré Hindmarsh 8, Lisa K Stamp 9, Nicola Dalbeth 10, Tony R Merriman 11 |
159 | |
Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation Population |
Prog Transplant. 2020 Jun;30(2):103-110. doi: 10.1177/1526924820913514. Epub 2020 Mar 25. Mark D Brigham 1, Andrew Milgroom 1, Mara Onita Lenco 1, Zheng Wang 1, Jeffrey D Kent 2, Brian LaMoreaux 2, Richard J Johnson 3, Brian F Mandell 4, Nandini Hadker 1, Herman Sanchez 1, Kevin Francis 1, Lauren P Radeck 1, Gavin Miyasato 1, Justin W Li 1 |
160 | |
Allopurinol hypersensitivity: Pathogenesis and prevention |
Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101501.doi: 10.1016/j.berh.2020.101501. Epub 2020 Apr 4. |
161 | |
C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1 |
Sci Rep. 2020 Apr 14;10(1):6391. doi: 10.1038/s41598-020-63318-8. Anika Alberts 1, Annika Klingberg 1, Anne Kathrin Wessig 1, Christèle Combes 2, Torsten Witte 3, Korbinian Brand 1, Andreas Pich 4, Konstantin Neumann 5 |
162 | |
2020 American College of Rheumatology Guideline for the Management of Gout |
Arthritis Rheumatol. 2020 Jun;72(6):879-895. doi: 10.1002/art.41247.Epub 2020 May 11. John D FitzGerald 1, Nicola Dalbeth 2, Ted Mikuls 3, Romina Brignardello-Petersen 4, Gordon Guyatt 4, Aryeh M Abeles 5, Allan C Gelber 6, Leslie R Harrold 7, Dinesh Khanna 8, Charles King 9, Gerald Levy 10, Caryn Libbey 11, David Mount 12, Michael H Pillinger 5, Ann Rosenthal 13, Jasvinder A Singh 14, James Edward Sims 15, Benjamin J Smith 16, Neil S Wenger 17, Sangmee Sharon Bae 17, Abhijeet Danve 18, Puja P Khanna 19, Seoyoung C Kim 20, Aleksander Lenert 21, Samuel Poon 22, Anila Qasim 4, Shiv T Sehra 23, Tarun Sudhir Kumar Sharma 24, Michael Toprover 5, Marat Turgunbaev 25, Linan Zeng 4, Mary Ann Zhang 20, Amy S Turner 25, Tuhina Neogi 11 |
163 | |
Effect of Bempedoic Acid on Serum Uric Acid and Related Outcomes: A Systematic Review and Meta-analysis of the available Phase 2 and Phase 3 Clinical Studies |
Drug Saf. 2020 Aug;43(8):727-736. doi: 10.1007/s40264-020-00931-6. Arrigo F G Cicero 1, Roberto Pontremoli 2, Federica Fogacci 3, Francesca Viazzi 2, Claudio Borghi 3 |
164 | |
Flare Rate Thresholds for Patient Assessment of Disease Activity States in Gout |
J Rheumatol. 2020 May 1;jrheum.191242. doi: 10.3899/jrheum.191242. Online ahead of print. William Taylor 1, Nicola Dalbeth 1, Kenneth G Saag 1, Jasvinder A Singh 1, Elizabeth J Rahn 1, Amy S Mudano 1, Yi-Hsing Chen 1, Ching-Tsai Lin 1, Paul Tan 1, Worawit Louthreno 1, Janitzia Vazquez-Mellado 1, Hansel Hernández-Llinas 1, Tuhina Neogi 1, Ana B Vargas-Santos 1, Geraldo Castelar-Pinheiro 1, Rodrigo B Chaves-Amorim 1, Tillman Uhlig 1, Hilde B Hammer 1, Maxim Eliseev 1, Fernando Perez-Ruiz 1, Lorenzo Cavagna 1, Geraldine M McCarthy 1, Lisa K Stamp 1, Martijin Gerritsen 1, Viktoria Fana 1, Francisca Sivera 1, Angelo L Gaffo 1 |
165 | |
Lessons and pitfalls from the 2020 Gout Clinical Practice Guideline presented in Atlanta at the ACR 2019 |
Clin Rheumatol. 2020 Jun;39(6):2011-2016. doi: 10.1007/s10067-020-05070-y.Epub 2020 Apr 21. Tim L Jansen 1, Matthijs Janssen 2 |
166 | |
Mortality in patients with gout treated with allopurinol: a systematic review and meta-analysis |
Arthritis Care Res (Hoboken). 2020 Apr 14. doi: 10.1002/acr.24205. Online ahead of print. Charles A Hay 1, James A Prior 1, John Belcher 1, Christian D Mallen 1, Edward Roddy 1 |
167 | |
Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data |
Ann Rheum Dis. 2020 Apr;79(4):529-535. doi: 10.1136/annrheumdis-2019-216917.Epub 2020 Feb 5. Jasvinder A Singh 1 2, John D Cleveland 3 |
168 | |
Management of Gout in the United States: A Claims-based Analysis |
ACR Open Rheumatol. 2020 Mar;2(3):180-187. doi: 10.1002/acr2.11121. Epub 2020 Mar 1 N Lawrence Edwards 1, Naomi Schlesinger 2, Sanders Clark 3, Theresa Arndt 3, Peter E Lipsky 4 |
169 | |
Epidemiology of Depression and Anxiety in Gout: A Systematic Review and Metaanalysis |
J Rheumatol. 2021 Jan 1;48(1):129-137. doi: 10.3899/jrheum.190974. Epub 2020 Mar 1. Alyssa Howren 1, Drew Bowie 2, Hyon K Choi 3, Sharan K Rai 4, Mary A De Vera 5 |